Olema Pharmaceuticals, Inc.
OLMA
$4.42
$0.163.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.86% | -13.74% | 1.90% | -15.68% | -24.51% |
| Total Depreciation and Amortization | 22.11% | 1.06% | 6.82% | 0.00% | -2.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.55% | 2.43% | 34.41% | 18.22% | -25.96% |
| Change in Net Operating Assets | -38.37% | 424.84% | -123.92% | -21.71% | 226.75% |
| Cash from Operations | 2.71% | 1.96% | -17.28% | -27.17% | 18.77% |
| Capital Expenditure | -- | 100.00% | 96.08% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -349.18% | 1,042.53% | 75.63% | 35.34% | -21.47% |
| Cash from Investing | -349.18% | 1,041.37% | 75.78% | 34.84% | -21.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 272,506.52% | -99.41% | 73.61% | 3,075.97% | -99.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 100.60% | -169.58% | 200.00% |
| Cash from Financing | 265,443.48% | -99.41% | 76.91% | 1,586.62% | -99.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 445.34% | 212.88% | 51.67% | 28.75% | -159.27% |